Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clarkhealthcommunications

- PMLiVE

Pfizer’s one-time haemophilia B therapy Durveqtix receives CHMP recommendation

More than 38,000 people worldwide are currently affected by the inherited bleeding disorder

- PMLiVE

Moderna/Merck share positive three-year results for investigational skin cancer vaccine

More than 100,000 new cases of melanoma are expected to be diagnosed in the US in 2024

- PMLiVE

Takeda’s enzyme replacement therapy recommended by CHMP for rare blood clotting disorder cTTP

If approved, rADAMTS13 will be the first and only enzyme replacement therapy in the EU indicated for cTTP

- PMLiVE

Eli Lilly commits further $6.5m to UNICEF for young people at risk of noncommunicable diseases

The new funding builds on the company’s initial commitment of $14.4m in 2022

- PMLiVE

Driving diversity in clinical research

The positive impact of technology-enabled trials in ensuring equal representation for all

- PMLiVE

Purposeful communications: matchmaking patient and HCP influencers to deliver the impact you want

By Katy Davidson

- PMLiVE

Natural intelligence: healthcare comms in 2024

By Clare Middleton and Katie McMorran

- PMLiVE

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...

Mtech Access

- PMLiVE

How to hack a problem like healthcare

To create the most compelling clinical and cost-benefit arguments, the quickest and most comprehensive answers come by ‘bringing the outside in’ and treating the problem as a ‘hack’.

EatMoreFruit

AMICULUM: Activating science, transforming health

From 4 June 2024 AMICULUM is bringing together our family of agencies under the AMICULUM® brand. All of our agencies were founded and owned by AMICULUM and the business continues...

AMICULUM

- PMLiVE

How are Research Skills Useful in Medical Communications?

Dr Abimbola Aminu examines how our team combine research skills with creativity

Mednet Group

- PMLiVE

Bristol Myers Squibb’s Breyanzi receives FDA approval for mantle cell lymphoma

The rare form of non-Hodgkin lymphoma accounts for around 3% of all NHL cases

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links